Literature DB >> 23998261

Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.

Nobuhiro Ohno1, Seiichiro Kobayashi, Tomohiro Ishigaki, Koichiro Yuji, Masayuki Kobayashi, Koota Sato, Nobukazu Watanabe, Arinobu Tojo, Kaoru Uchimaru.   

Abstract

Entities:  

Keywords:  CC chemokine receptor 4; adult T-cell leukaemia-lymphoma; flow cytometry; mogamulizumab; monoclonal antibody

Mesh：

Substances：

Year:  2013        PMID： 23998261     DOI： 10.1111/bjh.12555

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential.

Authors:  Madeleine Duvic; Mark Evans; Casey Wang
Journal:  Ther Adv Hematol       Date:  2016-03-17

2.  CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.

Authors:  Jérôme Giustiniani; Gabor Dobos; Hélène Moins-Teisserenc; Tiago Eustaquio; Maxime Battistella; Nicolas Ortonne; Caroline Ram-Wolff; Jean-David Bouaziz; Anne Marie-Cardine; Samia Mourah; Martine Bagot; Thomas S Kupper; Rachael A Clark; Armand Bensussan; Adèle de Masson
Journal:  Blood Adv       Date:  2022-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.